derived from @amb005 (thanks for the share) article above...$33m market cap and a leader in europe. sounds like that's where the focus should be rather than the US where every man and hisis involved.
"...Benhaim can take solace in knowing Elixinol is still a leader in the UK and Europe, a growth market where it has a strong position in hemp-derived CBD nutraceuticals. But structural challenges remain in the US Elixinol LLC itself hails from Colorado where a slower than expected regulatory progress prevails, leading to an "under-regulated, oversupplied and highly competitive market".
Short term technical outlook EXL, page-8
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $3.963M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $241 | 80.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1120584 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 5433240 | 13 |
View Market Depth
| Last trade - 13.44pm 09/08/2024 (20 minute delay) ? |
| EXL (ASX) Chart |